Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Itraconazole
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021
EK1C4
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/20/2021
EK1
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/20/2021
Nafamostat mesylate
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021
Alpha-1 antitrypsin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/19/2021
GS‐441524
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/19/2021
S2GΔHR2 I3-01v9 SApNP
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/19/2021
Adenosine
Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/18/2021
Irbesartan
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Alvimopan
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Darifenacin
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/18/2021
Nebivolol
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021
Bictegravir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021
17-alpha-Hydroxywithanolide D
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
Withanolide R
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
6-Thioguanosine 5'-diphosphate
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
Coagulin Q
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
Pralatrexate
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/17/2021
P5A-3C12
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
P5A-2F11
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021